Atezolizumab Intravenous and Insulin Degludec (U-100) Vials
Determining the interaction of Atezolizumab Intravenous and Insulin Degludec (U-100) Vials and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: atezolizumab
Brand name: Tecentriq
Synonyms: Atezolizumab
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Atezolizumab Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Atezolizumab Intravenous-Insulin degludec and liraglutide
- Atezolizumab Intravenous-Insulin degludec and liraglutide Subcutaneous
- Atezolizumab Intravenous-Insulin degludec Subcutaneous
- Atezolizumab Intravenous-Insulin detemir
- Atezolizumab Intravenous-Insulin Detemir (Cartridges and Prefilled Syringes)
- Insulin Degludec (U-100) Vials-Atgam
- Insulin Degludec (U-100) Vials-Atgam equine
- Insulin Degludec (U-100) Vials-Ativan
- Insulin Degludec (U-100) Vials-Ativan (Lorazepam Injection Solution)
- Insulin Degludec (U-100) Vials-Ativan (Lorazepam Tablets)
- Insulin Degludec (U-100) Vials-Ativan injection